How new treatments will transform the specialty

'We really are in a golden age of therapeutics for inflammatory joint disease,' says Dr Mona Marabani

In the final article of our three part series 'The Rheumatology Revolution' we report on developments in patient access to therapies for rheumatological diseases, including the latest news from 2018’s largest rheumatology conference on treating rare and severe disease.

Read Part 1: 'Poor image: Why the musculoskeletal field needs a makeover' and Part 2: '